EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics

Rebecca van Grootveld iD, Judith van Paassen iD, Eric C J Claas, Laura Heerdink, Ed J Kuijper, Mark G J de Boer, Martha T van der Beek, LUMC-COVID-19 Research Group

Medical Mycology · 2024

DOI: 10.1093/mmy/myae028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Mycology, 2024. Verfasst von Rebecca van Grootveld und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Intensive Care Units, Invasive Pulmonary Aspergillosis, Mass Screening. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnostic performance of a prospective, systematic screening strategy for COVID-19 associated pulmonary aspergillosis (CAPA) during the COVID-19 pandemic was investigated. Patients with COVID-19 admitted to the ICU were screened for CAPA twice weekly by collection of tracheal aspirate (TA) for Aspergillus culture and PCR. Subsequently, bronchoalveolar lavage (BAL) sampling was performed in patients with positive screening results and clinical suspicion of infection. Patient data were collected from April 2020–February 2022. Patients were classified according to 2020 ECMM/ISHAM consensus criteria. In total, 126/370 (34%) patients were positive in screening and CAPA frequency was 52/370 (14%) (including 13 patients negative in screening). CAPA was confirmed in 32/43 (74%) screening positive patients who underwent BAL sampling. ICU mortality was 62% in patients with positive screening and confirmed CAPA, and 31% in CAPA cases who were screening negative. The sensitivity, specificity, positive and negative predictive value (PPV & NPV) of screening for CAPA were 0.71, 0.73, 0.27, and 0.95, respectively. The PPV was higher if screening was culture positive compared to PCR positive only, 0.42 and 0.12 respectively. CAPA was confirmed in 74% of screening positive patients, and culture of TA had a better diagnostic performance than PCR. Positive screening along with clinical manifestations appeared to be a good indication for BAL sampling since diagnosis of CAPA was confirmed in most of these patients. Prospective, systematic screening allowed to quickly gain insight into the epidemiology of fungal superinfections during the pandemic and could be applicable for future pandemics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Intensive Care UnitsInvasive Pulmonary AspergillosisMass ScreeningHumansProspective StudiesMaleFemaleMiddle AgedAgedSensitivity and SpecificitySARS-CoV-2Bronchoalveolar Lavage FluidAdultAspergillus

Autor:innen und Institutionen

  • Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Medical Microbiology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
  • Department of Intensive Care, Leiden University Medical Center, Leiden, The Netherlands.
  • Directorate of Education (DOO), Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.

ORCID-Profile: Rebecca van Grootveld, Judith van Paassen

Zitieren

APA

van Grootveld, R., van Paassen, J., Claas, E. C. J., Heerdink, L., Kuijper, E. J., de Boer, M. G. J., van der Beek, M. T., & LUMC-COVID-19 Research Group (2024). Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics. Medical Mycology. https://doi.org/10.1093/mmy/myae028

Vancouver

van Grootveld R, van Paassen J, Claas ECJ, Heerdink L, Kuijper EJ, de Boer MGJ, et al. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics. Medical Mycology. 2024. doi:10.1093/mmy/myae028

BibTeX
@article{vanGrootveld2024,
  author = {van Grootveld, Rebecca and van Paassen, Judith and Claas, Eric C J and Heerdink, Laura and Kuijper, Ed J and de Boer, Mark G J and van der Beek, Martha T and LUMC-COVID-19 Research Group, LUMC-COVID-19 Research Group},
  title = {Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae028}
}
Kostenlos starten →